| 1 | [SID103177051] | Active | IC50 | 0.000902 | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) [AID625222, Type: other] | Sodium-dependent serotonin transporter [gi:400630] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.000902 [uM] | | BioAssay | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | | AID | 625222 | | BioAssay type | other | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | | | Data Table |  |
|
| 2 | [SID103177051] | Active | IC50 | 0.000902 | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) [AID625222, Type: other] | Sodium-dependent serotonin transporter [gi:400630] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.000902 [uM] | | BioAssay | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | | AID | 625222 | | BioAssay type | other | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | | | Data Table |  |
|
| 3 | [SID103177051] | Active | IC50 | 0.000902 | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) [AID625222, Type: other] | Sodium-dependent serotonin transporter [gi:400630] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.000902 [uM] | | BioAssay | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | | AID | 625222 | | BioAssay type | other | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | | | Data Table |  |
|
| 4 | [SID103177051] | Active | Ki | 0.0015 | Inhibition of [3H]citalopram binding to Serotonin transporter of rat cerebral cortex [AID204703, Type: Literature] | Sodium-dependent serotonin transporter [gi:400629] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0015 [uM] | | BioAssay | Inhibition of [3H]citalopram binding to Serotonin transporter of rat cerebral cortex | | AID | 204703 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400629] | | PubMed | 10915050 | | Data Table |  |
|
| 5 | [SID103177051] | Active | Ki | 0.0016 | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells [AID204199, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0016 [uM] | | BioAssay | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells | | AID | 204199 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 14971892 | | Data Table |  |
|
| 6 | [SID103177051] | Active | Ki | 0.0016 | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells [AID204199, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0016 [uM] | | BioAssay | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells | | AID | 204199 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 14971892 | | Data Table |  |
|
| 7 | [SID103177051] | Active | Ki | 0.0016 | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells [AID204199, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0016 [uM] | | BioAssay | Inhibition of [125I]RTI-55 binding to human serotonin transporter expressed in human embryonic kidney cells | | AID | 204199 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 14971892 | | Data Table |  |
|
| 8 | [SID103177051] | Active | Ki | 0.0016 | Displacement of [3H]paroxetine from serotonin transporter of rat cerebral cortex [AID239125, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0016 [uM] | | BioAssay | Displacement of [3H]paroxetine from serotonin transporter of rat cerebral cortex | | AID | 239125 | | BioAssay type | Literature | | Target | | | PubMed | 15686927 | | Data Table |  |
|
| 9 | [SID103177051] | Active | IC50 | 0.0018 | Inhibition of 5-HT uptake in rat synaptosomal fraction [AID179069, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.0018 [uM] | | BioAssay | Inhibition of 5-HT uptake in rat synaptosomal fraction | | AID | 179069 | | BioAssay type | Literature | | Target | | | PubMed | 2999402 | | Data Table |  |
|
| 10 | [SID103177051] | Active | Ki | 0.00194 | Displacement of [3H]citalopram from SERT in rat brain stem by scintillation counting [AID499947, Type: Literature] | Sodium-dependent serotonin transporter [gi:400629] |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00194 [uM] | | BioAssay | Displacement of [3H]citalopram from SERT in rat brain stem by scintillation counting | | AID | 499947 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400629] | | PubMed | 20672825 | | Data Table |  |
|
| 11 | [SID103177051] | Active | Ki | 0.0029 | Tested in vitro for serotonin(5-HT) neuronal uptake inhibition [AID134217, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0029 [uM] | | BioAssay | Tested in vitro for serotonin(5-HT) neuronal uptake inhibition | | AID | 134217 | | BioAssay type | Literature | | Target | | | PubMed | 2213832 | | Data Table |  |
|
| 12 | [SID103177051] | Active | IC50 | 0.00317 | Inhibition of [3H]5-HT reuptake at rat SERT expressed in HEK293 cells after 2 mins by liquid scintillation counting [AID471630, Type: Literature] | Sodium-dependent serotonin transporter [gi:400629] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.00317 [uM] | | BioAssay | Inhibition of [3H]5-HT reuptake at rat SERT expressed in HEK293 cells after 2 mins by liquid scintillation counting | | AID | 471630 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400629] | | PubMed | 19717215 | | Data Table |  |
|
| 13 | [SID103177051] | Active | Ki | 0.00438 | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells [AID361595, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00438 [uM] | | BioAssay | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | | AID | 361595 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18644726 | | Data Table |  |
|
| 14 | [SID103177051] | Active | Ki | 0.00438 | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells [AID361595, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00438 [uM] | | BioAssay | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | | AID | 361595 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18644726 | | Data Table |  |
|
| 15 | [SID103177051] | Active | Ki | 0.00438 | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells [AID361595, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00438 [uM] | | BioAssay | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | | AID | 361595 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18644726 | | Data Table |  |
|
| 16 | [SID103177051] | Active | Ki | 0.00438 | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells [AID408801, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00438 [uM] | | BioAssay | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | | AID | 408801 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18487050 | | Data Table |  |
|
| 17 | [SID103177051] | Active | Ki | 0.00438 | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells [AID408801, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00438 [uM] | | BioAssay | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | | AID | 408801 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18487050 | | Data Table |  |
|
| 18 | [SID103177051] | Active | Ki | 0.00438 | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells [AID408801, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.00438 [uM] | | BioAssay | Displacement of [3H]citalopram from human SERT expressed in HEK293 cells | | AID | 408801 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18487050 | | Data Table |  |
|
| 19 | [SID103177051] | Active | IC50 | 0.019 | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay [AID576813, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.019 [uM] | | BioAssay | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay | | AID | 576813 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 21227702 | | Data Table |  |
|
| 20 | [SID103177051] | Active | IC50 | 0.019 | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay [AID576813, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.019 [uM] | | BioAssay | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay | | AID | 576813 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 21227702 | | Data Table |  |
|
| 21 | [SID103177051] | Active | IC50 | 0.019 | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay [AID576813, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.019 [uM] | | BioAssay | Inhibition of [3H]-serotonin reuptake at human SERT expressed in HEK293 cells after 15 to 20 mins by fluorescence neurotransmitter transporter assay | | AID | 576813 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 21227702 | | Data Table |  |
|
| 22 | [SID103177051] | Active | Ki | 0.0328 | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells [AID408802, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0328 [uM] | | BioAssay | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | | AID | 408802 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18487050 | | Data Table |  |
|
| 23 | [SID103177051] | Active | Ki | 0.0328 | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells [AID408802, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0328 [uM] | | BioAssay | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | | AID | 408802 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18487050 | | Data Table |  |
|
| 24 | [SID103177051] | Active | Ki | 0.0328 | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells [AID408802, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0328 [uM] | | BioAssay | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | | AID | 408802 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18487050 | | Data Table |  |
|
| 25 | [SID103177051] | Active | Ki | 0.0328 | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells [AID361596, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0328 [uM] | | BioAssay | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | | AID | 361596 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18644726 | | Data Table |  |
|
| 26 | [SID103177051] | Active | Ki | 0.0328 | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells [AID361596, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0328 [uM] | | BioAssay | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | | AID | 361596 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18644726 | | Data Table |  |
|
| 27 | [SID103177051] | Active | Ki | 0.0328 | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells [AID361596, Type: Literature] | Sodium-dependent serotonin transporter [gi:400630] |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | Ki | 0.0328 [uM] | | BioAssay | Displacement of [3H]paroxetine from human SERT expressed in HEK293 cells | | AID | 361596 | | BioAssay type | Literature | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | 18644726 | | Data Table |  |
|
| 28 | [SID103177051] | Active | IC50 | 0.297 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.297 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 29 | [SID103177051] | Active | IC50 | 0.297 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.297 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 30 | [SID103177051] | Active | IC50 | 0.297 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) [AID625218, Type: other] | 5-hydroxytryptamine receptor 2C [gi:112816] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.297 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | | AID | 625218 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2C [gi:112816] | | PubMed | | | Data Table |  |
|
| 31 | [SID103177051] | Active | IC50 | 0.398 | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) [AID625223, Type: other] | Sigma non-opioid intracellular receptor 1 [gi:74752153] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.398 [uM] | | BioAssay | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | | AID | 625223 | | BioAssay type | other | | Target | Sigma non-opioid intracellular receptor 1 [gi:74752153] | | PubMed | | | Data Table |  |
|
| 32 | [SID103177051] | Active | IC50 | 0.398 | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) [AID625223, Type: other] | Sigma non-opioid intracellular receptor 1 [gi:74752153] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 0.398 [uM] | | BioAssay | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | | AID | 625223 | | BioAssay type | other | | Target | Sigma non-opioid intracellular receptor 1 [gi:74752153] | | PubMed | | | Data Table |  |
|
| 33 | [SID103177051] | Active | IC50 | 1.025 | DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888)) [AID625234, Type: other] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 1.025 [uM] | | BioAssay | DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888)) | | AID | 625234 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID103177051] | Active | IC50 | 1.756 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625198, Type: other] | Alpha-1D adrenergic receptor [gi:1168244] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 1.756 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625198 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168244] | | PubMed | | | Data Table |  |
|
| 35 | [SID103177051] | Active | IC50 | 1.786 | DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem) [AID625215, Type: other] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 1.786 [uM] | | BioAssay | DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem) | | AID | 625215 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID103177051] | Active | IC50 | 1.839 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 1.839 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 37 | [SID103177051] | Active | IC50 | 1.839 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 1.839 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 38 | [SID103177051] | Active | IC50 | 1.839 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 1.839 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 39 | [SID103177051] | Active | IC50 | 2.196 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) [AID625207, Type: other] | Sodium-dependent noradrenaline transporter [gi:128616] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 2.196 [uM] | | BioAssay | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | | AID | 625207 | | BioAssay type | other | | Target | Sodium-dependent noradrenaline transporter [gi:128616] | | PubMed | | | Data Table |  |
|
| 40 | [SID103177051] | Active | IC50 | 2.196 | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) [AID625207, Type: other] | Sodium-dependent noradrenaline transporter [gi:128616] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 2.196 [uM] | | BioAssay | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | | AID | 625207 | | BioAssay type | other | | Target | Sodium-dependent noradrenaline transporter [gi:128616] | | PubMed | | | Data Table |  |
|
| 41 | [SID103177051] | Active | IC50 | 2.641 | DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin) [AID625225, Type: other] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 2.641 [uM] | | BioAssay | DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin) | | AID | 625225 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID103177051] | Active | IC50 | 3.194 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.194 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 43 | [SID103177051] | Active | IC50 | 3.194 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.194 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 44 | [SID103177051] | Active | IC50 | 3.288 | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.288 [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 45 | [SID103177051] | Active | IC50 | 3.288 | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.288 [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 46 | [SID103177051] | Active | IC50 | 3.289 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.289 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|
| 47 | [SID103177051] | Active | IC50 | 3.289 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.289 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|
| 48 | [SID103177051] | Active | IC50 | 3.289 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.289 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|
| 49 | [SID103177051] | Active | IC50 | 3.98107 | Inhibitory concentration against potassium channel HERG [AID243151, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.98107 [uM] | | BioAssay | Inhibitory concentration against potassium channel HERG | | AID | 243151 | | BioAssay type | Literature | | Target | | | PubMed | 15911273 | | Data Table |  |
|
| 50 | [SID103177051] | Active | IC50 | 3.98107 | Inhibition of human Potassium channel HERG expressed in mammalian cells [AID161281, Type: Literature] | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103177051 | | CID | 2771 | | Outcome | Active | | IC50 | 3.98107 [uM] | | BioAssay | Inhibition of human Potassium channel HERG expressed in mammalian cells | | AID | 161281 | | BioAssay type | Literature | | Target | Potassium voltage-gated channel subfamily H member 2 [gi:7531135] | | PubMed | 12873512 | | Data Table |  |
|